Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta
  2. Ganta, Krishna Kumar; McManus, Margaret; Blanc, Ross; Wang, Qixin; Jung, Wonyeong; Brody, Robin; Carrington,Mary; Paris, Robert; Chandramouli, Sumana; McNamara, Ryan P; Luzuriaga, Katherine
  3. Cell Reports. 2025, May 13; 44(5): 115709.
  1. 2.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 3.   Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008
  2. Sabourin, Katherine R; Mugisha, Joseph; Asiki, Gershim; Nalwoga, Angela; Labo,Nazzarena; Miley,Wendell; Beyer, Rachel; Rochford, Rosemary; Johnston, Thomas W; Newton, Robert; Whitby,Denise
  3. Infectious Agents and Cancer. 2023, Sep 29; 18(1): 55.
  1. 4.   Patients with NK cell chronic active EBV have immature NK cells and hyperactivation of PI3K/Akt/mTOR and STAT1 pathways
  2. Howe, Matthew K; Dowdell, Kennichi; Kuehn, Hye Sun; Li, Qingxue; Hart, Geoffrey T; Garabedian, Doreen; Liepshutz,Kelly; Hsu, Amy P; Su, Hua; Niemela, Julie E; Stoddard, Jennifer L; Uzel, Gulbu; Shereck, Evan; Schulz, Laura; Feldman, Tatyana; Rosenzweig, Sergio D; Long, Eric O; Dropulic, Lesia; Cohen, Jeffrey I
  3. The Journal of infectious diseases. 2020, OCT 1; 222(7): 1170-1179.
  1. 5.   Mutual detection of Kaposi's sarcoma-associated-Herpesvirus and Epstein Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma
  2. Labo,Nazzarena; Marshall,Vickie; Miley,Wendell; Davis, Eliza; McCann,Brendan; Stolka, Kristen B; Ndom, Paul; Hemingway-Foday, Jennifer J; Abassora, Mahamat; Newton, Robert; Smith, Jennifer S; Whitby,Denise
  3. International journal of cancer. 2019, JUL 18;
  1. 6.   Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
  2. Bu, Wei; Joyce, M. Gordon; Banh, Dalton V.; Aguilar, Fiona; Tariq, Zeshan; Yap, Moh Lan; Tsujimura, Yusuke; Gillespie, Rebecca A.; Tsybovsky,Yaroslav; Andrews, Sarah F.; Narpala, Sandeep R.; McDermott, Adrian B.; Rossmann, Michael G.; Yasutomi, Yasuhiro; Nabel, Gary J.; Kanekiyo, Masaru; Cohen, Jeffrey I.
  3. Immunity. 2019, May 21; 50(5): 1305-1316.e6.
  1. 7.   Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan
  2. Yang, X. H. R.; Goldstein, A. M.; Chen, C. J.; Rabkin, C. S.; Chen, J. Y.; Cheng, Y. J.; Hsu, W. L.; Sun, B.; Diehl, S. R.; Liu, M. Y.; Walters, M.; Shao, W.; Ortiz-Conde, B. A.; Whitby, D.; Elmore, S. H.; Gulley, M. L.; Hildesheim, A.
  3. International Journal of Cancer. 2006, MAR 1; 118(3): 780-784.
  1. 8.   High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs
  2. Mbulaiteye, S. M.; Walters, M.; Engels, E. A.; Bakaki, P. M.; Ndugwa, C. M.; Owor, A. M.; Goedert, J. J.; Whitby, D.; Biggar, R. J.
  3. Journal of Infectious Diseases. 2006, FEB 1; 193(3): 422-426.
  1. 9.   Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line
  2. Song, X.; Tao, Y. G.; Zeng, L.; Deng, X. Y.; Lee, L. M.; Gong, J. P.; Wu, Q.; Cao, Y.
  3. Virus Research. 2005, NOV; 113(2): 89-99.
  1. 10.   Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma
  2. Kovacic, M. B.; Martin, M.; Gao, X. J.; Fuksenko, T.; Chen, C. J.; Cheng, Y. J.; Chen, J. Y.; Apple, R.; Hildesheim, A.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 1): 2673-2677.
  1. 11.   Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis
  2. Lu, Z. X.; Ye, M.; Yan, G. R.; Li, Q.; Tang, M.; Lee, L. M.; Sun, L. Q.; Cao, Y.
  3. Cancer Gene Therapy. 2005, JUL; 12(7): 647-654.
  1. 12.   Azidothymidine inhibits NF-kappa B and induces Epstein-Barr virus gene expression in Burkitt lymphoma
  2. Kurokawa, M.; Ghosh, S. K.; Ramos, J. C.; Mian, A. M.; Toomey, N. L.; Cabral, L.; Whitby, D.; Barber, G. N.; Dittmer, D. P.; Harrington, W. J.
  3. Blood. 2005, JUL 1; 106(1): 235-240.
  1. 13.   Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1
  2. Tao, Y. G.; Xing, S.; Deng, X. Y.; Xie, D. X.; Lee, L. M.; Liu, Y. P.; Wei, L.; Li, L. L.; Lin, D.; Qiao, W.; Gong, J. P.; Ya, C.
  3. Experimental Cell Research. 2005, FEB 15; 303(2): 240-251.
  1. 14.   Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein Barr virus encoded latent membrane protein 1
  2. Song, X.; Tao, Y. G.; Tan, Y. N.; Lee, L. M.; Deng, X. Y.; Wu, Q.; Cao, Y.
  3. Science in China Series C-Life Sciences. 2005, FEB; 48(1): 70-80.
  1. 15.   Synthesis of conformationally locked carbocyclic nucleosides built on an oxabicyclo 3.1.0 hexane system
  2. Comin, M. J.; Rodriguez, J. B.; Russ, P.; Marquez, V. E.
  3. Tetrahedron. 2003 59(3): 295-301.
  1. 16.   A novel Epstein-Barr virus-like virus, HVMNE, in a Macaca nemestrina with mycosis fungoides
  2. Rivadeneira, E. D.; Ferrari, M. G.; Jarrett, R. F.; Armstrong, A. A.; Markham, P.; Birkebak, T.; Takemoto, S.; Johnson-Delaney, C.; Pecon-Slattery, J.; Clark, E. A.; Franchini, G.
  3. Blood. 1999 94(6): 2090-2101.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel